Latest Cash Flow News

Reliance Worldwide Corporation has announced an additional A$120 million on-market share buy-back, reinforcing its confidence in the company’s strategy and financial health.

Dalrymple Bay Infrastructure has successfully priced a $350 million five-year bond, marking its debut in the Australian Medium-Term Note market with robust investor demand.

The Brazilian government has imposed a 12% tax on crude oil exports effective immediately, a move framed as windfall profit sharing amid high oil prices. Karoon Energy, with significant Brazilian operations, faces new cost pressures as the tax awaits potential ratification by Congress.

Excite Technology Services has secured $1.05 million through convertible notes, aiming to capitalise on its strongest operational cash flow quarter and accelerate growth.

OzAurum Resources has kicked off an 18,000-metre drilling campaign at its Mulgabbie North Gold Project, aiming to confirm high-grade gold zones and accelerate its pathway to production.

Forte Energy has completed a major acquisition of oil leases in Alaska’s National Petroleum Reserve, with technical work underway on the promising Harrier Prospect and cost-saving lease fee suspensions boosting near-term flexibility.

Australian Oil Company Limited has formalised a 12-month crude oil lifting agreement with IOR Energy for its Emu Apple Oil Field, paving the way for steady cash flow and further development in the Surat Basin.

Everest Metals Corporation reports outstanding high-grade gold intersections from its latest drilling at Mt Dimer Taipan, underpinning imminent mining and processing milestones. The project is fully funded and on track for near-term cash flow.

Challenger Limited has updated its dividend announcement, confirming the suspension of its Dividend Reinvestment Plan (DRP) for the current period. Shareholders will receive a fully franked cash dividend of AUD 0.155 per share on 24 March 2026.

Shriro Holdings Limited has announced a $15 million off-market share buy-back at $0.81 per share, representing nearly 26% of its issued capital. The move aims to return excess capital to shareholders while supporting the company’s capital-light growth model.

Acrux Limited has secured a $0.55 million advance on its FY26 R&D Tax Incentive, providing crucial funding to accelerate development of its Hormone Replacement Therapy following FDA regulatory confirmation.

ActivEX Limited has completed a $421,752 share placement, issuing over 21 million shares at 2 cents each, to fund its exploration projects and support working capital. The shares are locked in escrow for 12 months, signaling a strategic move to strengthen its financial footing.